RAYMOND JAMES TRUST N.A. – Eli Lilly and Company Transaction History
RAYMOND JAMES TRUST N.A. portfolio value:
$10.16M
portfolio value
RAYMOND JAMES TRUST N.A. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.57% | 177 shares | 29K | $323.35 | 31.42K |
| Q2 2022 | share | Decrease | -2.94% | -948 shares | 912K | $324.23 | 31.24K |
| Q1 2022 | share | Decrease | -0.75% | -243 shares | 260K | $286.37 | 32.19K |
| Q4 2021 | share | Decrease | -13.42% | -5.02K shares | 304K | $277.25 | 32.43K |
| Q3 2021 | share | Decrease | -13.13% | -5.66K shares | -1.24M | $230.3 | 37.46K |
| Q2 2021 | share | Increase | +0.80% | 344 shares | 1.90M | $228.04 | 43.12K |
| Q1 2021 | share | Decrease | -9.46% | -4.47K shares | 15K | $184.81 | 42.78K |
| Q4 2020 | share | Decrease | -3.98% | -1.95K shares | 695K | $166.32 | 47.25K |
| Q3 2020 | share | Decrease | -0.10% | -47 shares | -804K | $145.05 | 49.20K |
| Q2 2020 | share | Decrease | -0.41% | -204 shares | 1.22M | $160.1 | 49.25K |
| Q1 2020 | share | Increase | +8.75% | 3.98K shares | 884K | $134.64 | 49.45K |
| Q4 2019 | share | Decrease | -6.89% | -3.36K shares | 515K | $126.91 | 45.47K |
| Q3 2019 | share | Increase | +18.73% | 7.70K shares | 904K | $107.36 | 48.84K |
| Q2 2019 | share | Increase | +1.37% | 555 shares | -708K | $105.74 | 41.13K |
| Q1 2019 | share | Increase | +1.45% | 582 shares | 637K | $123.17 | 40.58K |
| Q4 2018 | share | Decrease | -2.17% | -887 shares | 241K | $109.26 | 40.00K |
| Q3 2018 | share | Increase | +0.21% | 84 shares | 906K | $100.8 | 40.88K |
| Q2 2018 | share | Increase | +1.31% | 527 shares | 366K | $79.72 | 40.80K |
| Q1 2018 | share | Decrease | -1.03% | -421 shares | -322K | $71.78 | 40.27K |
| Q4 2017 | share | Decrease | -7.26% | -3.18K shares | -316K | $77.79 | 40.69K |
| Q3 2017 | share | Increase | +0.57% | 249 shares | 163K | $78.29 | 43.88K |
| Q2 2017 | share | Decrease | -2.58% | -1.15K shares | -176K | $74.85 | 43.63K |
| Q1 2017 | share | Increase | +1.01% | 446 shares | 506K | $76 | 44.79K |
| Q4 2016 | share | Decrease | -0.11% | -51 shares | -303K | $66.02 | 44.34K |
| Q3 2016 | share | Decrease | -2.86% | -1.30K shares | -36K | $71.57 | 44.39K |
| Q2 2016 | share | Increase | +3.67% | 1.61K shares | 425K | $69.79 | 45.70K |
| Q1 2016 | share | Increase | +54.17% | 15.49K shares | 765K | $63.39 | 44.08K |